Amyotrophic lateral sclerosis - Latest research and news - Nature
Nov 7, 2024 · Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder that is marked by fasciculation, spasticity and progressive weakness of muscles, and results in...
Amyotrophic Lateral Sclerosis News -- ScienceDaily
Mar 13, 2024 · Latest research news on amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, including experimental treatments.
National Academies Releases Road Map for Turning ALS from …
June 18, 2024 (Arlington, VA) – The ALS Association commends the National Academies for its groundbreaking new report on amyotrophic lateral sclerosis (ALS). The report, the result of an 18-month study, provides a comprehensive road map aimed at …
Discovery of hundreds of genes potentially associated with ALS …
Jan 18, 2022 · Stanford researchers identified a gene crucial to the formation of toxic proteins in amyotrophic lateral sclerosis and showed how it could inform potential therapies for the disease.
New therapeutic strategy to reduce neuronal death in amyotrophic ...
Nov 16, 2023 · Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that affects neurons in the brain and spinal cord causing loss of muscle control. Scientists have now suggested a...
FDA Approves First ALS Treatment Via Accelerated Approval
Apr 25, 2023 · Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord. Over the course of the disease, people lose the ability to move, to speak, and eventually, to breathe. On average, it takes about a year before a final ALS diagnosis is made.
The amyotrophic lateral sclerosis exposome: recent advances
Sep 14, 2023 · Amyotrophic lateral sclerosis (ALS) is a fatal disease of motor neuron degeneration, with both genetic and environmental factors contributing to the risk and rate of disease progression....
Amyotrophic lateral sclerosis: a neurodegenerative disorder …
Dec 21, 2022 · Amyotrophic lateral sclerosis (ALS), with a lifetime risk of ~1/350, represents an area of huge unmet need and is a useful model of neurodegeneration, with measurable changes in motor...
Study finds genetic variant among people who experience a rare …
Jul 30, 2024 · Though exceedingly rare, some people diagnosed with amyotrophic lateral sclerosis (ALS) partially or fully recover from the lethal neurodegenerative disease. A better understanding of this...
Epigenomic analysis sheds light on risk factors for ALS
May 2, 2024 · In a study of cells from nearly 400 amyotrophic lateral sclerosis (ALS) patients, MIT researchers identified genomic regions with chemical modifications linked to disease progression.